FDA — authorised 10 December 1999
- Status: approved
🇺🇸 Hydroquinone Methyl Ether in United States
FDA authorised Hydroquinone Methyl Ether on 10 December 1999
Marketing authorisations
FDA — authorised 10 December 1999
- Application: NDA020922
- Marketing authorisation holder: ALMIRALL
- Local brand name: SOLAGE
- Indication: SOLUTION — TOPICAL
- Status: approved
Hydroquinone Methyl Ether in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Hydroquinone Methyl Ether approved in United States?
Yes. FDA authorised it on 10 December 1999; FDA authorised it on 10 December 1999.
Who is the marketing authorisation holder for Hydroquinone Methyl Ether in United States?
Marketing authorisation holder not available in our data.